Koers Koninklijke DSM N.V. Other OTC
Aandelen
RDSMY
US7802491081
consumenten goederen conglomeraten
Omzet 2024 * | 12,66 mld. 13,59 mld. | Omzet 2025 * | 13,3 mld. 14,28 mld. | Marktkapitalisatie | 27,52 mld. 29,54 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 492 mln. 528 mln. | Nettowinst (verlies) 2025 * | 791 mln. 849 mln. | EV/omzet 2024 * | 2,4 x |
Nettoschuld 2024 * | 2,88 mld. 3,09 mld. | Nettoschuld 2025 * | 2,65 mld. 2,84 mld. | EV/omzet 2025 * | 2,27 x |
K/w-verhouding 2024 * |
57,5
x | K/w-verhouding 2025 * |
34,5
x | Werknemers | - |
Dividendrendement 2024 * |
2,36% | Dividendrendement 2025 * |
2,38% | Vrij verhandelbaar | 25,03% |
Recentste transcriptie over Koninklijke DSM N.V.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-01-90 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 01-09-23 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-02-23 | |
Thomas Leysen
CHM | Chairman | 63 | 01-02-23 |
Director/Board Member | 62 | 01-02-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,76% | 867 mld. | |
0,00% | 239 mld. | |
+27,43% | 178 mld. | |
-7,66% | 126 mld. | |
+42,13% | 87,08 mld. | |
-7,60% | 72,31 mld. | |
-11,44% | 53,57 mld. | |
-26,17% | 37,73 mld. | |
+41,87% | 38,5 mld. |